Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Genmab and Seattle Genetics to collaborate on antibody-drug conjugates

Sep. 15, 2010

Bachem and Atheris collaborate on Melusine peptide toxin libraries

Sep. 15, 2010

Argenta and Genentech expand collaboration to include BioFocus

Sep. 14, 2010

Vaxin and Stabilitech to collaborate in developing anthrax vaccine

Sep. 14, 2010

RedHill Biopharma completes transactions for drugs in late-stage clinical development

Sep. 13, 2010

Anchor Therapeutics and Ortho-McNeil-Janssen to codevelop GPCR-targeted drugs

Sep. 13, 2010

Shire and Acceleron sign exclusive license agreement for ACTR-IIB molecules

Sep. 13, 2010

Santarus, S2 Therapeutics and VeroScience sign license agreement for Cycloset

Sep. 10, 2010

Transgene and Jennerex enter into exclusive partnership for JX-594

Sep. 9, 2010

Onyx and Ono sign Japanese agreements for oncology drugs carfilzomib and ONX-0912

Sep. 8, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...